MARAbio launches first blood test to detect maternal autoantibody-linked autism
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
The initiative is focused on a problem that continues to plague cancer outcomes in India
The move strengthens GBL’s clinical-stage presence in the United States
The company operates a chain of mid-sized multi-speciality hospitals
Imsidolimab, an IgG4 IL-36 receptor antagonist, works by inhibiting IL-36 receptor signaling, directly addressing the deficiency in the IL-36RA regulator common in GPP patients
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Subscribe To Our Newsletter & Stay Updated